Investors are advised to be aware of clues given by a biotechnology company’s financial reports before they invest in the highly unpredictable sector, experts said at a forum yesterday.
Growth prospects, technical capacity, and capital reserves are the main factors to consider in assessing the viability of investing in a biotechnology company, PricewaterhouseCoopers (PwC) Taiwan deputy chairman Audrey Tseng (曾惠瑾) said.
Growth prospects encompasses the business model of a company, and the terms it has established with its distributors that determine licensing schemes and milestone payments upon regulatory approval and reaching of sales targets, Tseng said
Regarding technical capacity, Tseng said that a new drug development company’s prospects can often been seen in its expenditure.
“We assess the rate of growth of research & development expenditure, and its proportion in relations to operating costs and consolidated revenues,” Tseng said.
A biotechnology firm’s survival depends on its cash reserves, she said.
In the event of a failed clinical trial, a company with ample cash might be able to bide its time and continue its research, while its cash-strapped peer perishes, she said.
“We also calculate the number of years a company might be able to continue operating in the black,” Tseng said, adding that she has found levels of cash reserves in the sector to be adequate.
Companies become defenseless when they have ran out of cash, and might have to turn over their unfinished work at bargain prices as their operations go into the red, she said, adding that a number of new drugs developed by Taiwanese companies are based on compounds acquired from foreign companies.
Tseng said that taxes on stock options remains a tremendous challenge for the sector.
In light of the lower salary for key researchers, companies often grant stock options, she added.
However, taxes are due upon the purchase of the new shares, and the expense adds to financial losses by researchers when the shares of their company swings wildly, she said.
‘BULLISH YEAR AHEAD’: The contract chipmaker set a growth target of up to 29 percent, as it expects to outperform its peers in the semiconductor industry Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is planning to boost this year’s capital expenditure budget by about 46 percent to exceed US$44 billion, citing strong customer demand for advanced technologies used in high-performance computing (HPC) and 5G-related applications, the world’s largest contract chipmaker said yesterday. The plan marks a record spending for TSMC after the chipmaker budgeted US$30 billion for capacity expansions at home and overseas fabs last year. TSMC is planning to allocate about 80 percent of this year’s capital spending for advanced chip capacity expansion including 2-nanometer, 3-nanometer, 5-nanometer and 7-nanometer technologies. The chipmaker reiterated that it is on
EMERGING TECH: The semiconductor equipment industry has had unprecedented growth, with increased spending in six of the past seven years, the CEO of SEMI said Global fab equipment spending at front-end facilities is expected to grow at an annual pace of 10 percent this year to a record of more than US$98 billion, with South Korea taking the lead, followed by Taiwan, SEMI said in a quarterly report yesterday. That means that world fab equipment spending is to grow for a third straight year, following a 39 percent jump last year and 17 percent growth in 2020, the global semiconductor trade association said in a statement. The industry previously had three consecutive years of growth from 2016 to 2018, more than 20 years after logging a three-year
Electric scooter maker Gogoro Inc (睿能創意) this year expects its number of electric battery swapping stations to outstrip the number of gas stations in the nation following seven years of deployment, a sign that electric two-wheelers are gaining traction. As of the end of last year, Gogoro had built 2,215 GoStations nationwide, mostly in urban areas, up from 1,937 in 2020. The number of gas stations operated by CPC Corp, Taiwan (台灣中油) and Formosa Petrochemical Corp (台塑石化) was 2,487. “By the end of this year, we are very confident that the number of battery swapping stations will surpass the number of gas stations
Siltronic AG cast doubt on a planned US$5.3 billion takeover by GlobalWafers Co (環球晶圓), saying the German Ministry of Economic Affairs and Climate Action’s feedback so far was opaque and offered no clear resolution on how to win approval for the deal. During recent discussions, the companies did not receive any information as to whether and under which conditions a clearance for the takeover might be issued, the German company said in a regulatory filing on Friday following a news report on remedies the companies have offered. In the ministry’s view “in this case, a mitigation agreement is apparently not suitable